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There is an emerging link between body mass and intest-
inal malignancies, and obese patients have ~20-60%
greater risk of, and ~2-fold greater mortality from, color-
ectal cancer. Although this epidemiological relationship is
established, mechanisms that link obesity and colorectal
tumorigenesis, and their reversibility, remain incompletely
defined. Here, we explore the novel hypothesis that obesity
and colorectal cancer are mechanistically linked through
dysregulation of paracrine and endocrine hormone axes
mediated by GUCY2C. GUCY2C is the receptor for the
paracrine hormones guanylin in the colorectum and uro-
guanylin in small intestine. These paracrine hormones are
the most commonly lost gene products in sporadic color-
ectal cancer, and their universal loss early in neoplasia is
required for tumor initiation and progression in mice and
humans. In that context, GUCY2C regulates intestinal
homeostasis, and its silencing by hormone loss accelerates
proliferation and the cell cycle, increases DNA damage,
and reprograms cellular metabolism, which increases
genetic- and carcinogen-induced colorectal cancer in
mice. Beyond its role in colorectal tumor suppression,
GUCY2C and uroguanylin comprise a novel gut-brain
endocrine axis, evolutionarily conserved from inverte-
brates to humans, that regulates appetite, body mass and
metabolism. Elimination of this endocrine axis in mice
results in hyperphagia, obesity, diabetes and the metabolic
syndrome. Unexpectedly, recent studies revealed that
GUCY2C paracrine hormone expression in colon is elimi-
nated by diet-induced obesity in mice and humans.
Indeed, hormone expression appears to be reversibly
modulated by ingested calories, rather than by the endo-
crine, adipokine or inflammatory milieu associated with
obesity. Moreover, enforced expression of GUCY2C
paracrine hormone by intestinal epithelial cells eliminates
tumorigenesis induced by obesity. These observations sug-
gest a model of cancer risk in which ingested calories con-
tributing to obesity recapitulate mechanisms underlying
sporadic colorectal cancer by suppressing paracrine hor-
mone expression, silencing the GUCY2C tumor suppres-
sor and disrupting epithelial homeostasis. They define a
previously unrecognized mechanism linking diet and obe-
sity to colorectal cancer and identify silencing of the
GUCY2C tumor suppressor as a link between reversible
risk factors like ingested calories and molecular mechan-
isms underlying cancer development. Moreover, they offer
strategies for countering these risks, including calorie
restriction and oral hormone therapy.
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